Location New York, United States, North America Regions East Coast, Northeastern US Gender Male Also Known As Dr Sam Yoon, Chief, Division of Surgical Oncology
Website drsamyoon.com/ LinkedIn View on LinkedIn X (Twitter) View on X
Since 2021, Sam Yoon has served as the Chief of the Division of Surgical Oncology and Vice-Chair of Surgical Oncology Research and Education at Columbia University Irving Medical Center. Known for his expertise in sarcomas, stomach, and gastroesophageal junction cancers, and gastrointestinal stromal tumors (GISTs), he leads critical clinical trials
and is a frequent speaker at international medical conferences, focusing on the urgent issues surrounding gastric cancer. This type of cancer is one of the leading causes of death worldwide, accounting for over a million new cases and 750,000 deaths each year.
His commitment to outstanding, patient-focused care has made him a highly respected figure in the tri-state area. His clinical excellence has been recognized multiple times, with accolades including being named one of the Best Doctors in America for 2010-2011 and again from 2017 to 2020. He practices at the CUIMC/Herbert Irving Pavilion in New York City, with additional locations in Bronxville, Cortland Manor in New York, and Englewood, New Jersey.
Sam began his educational journey at Harvard University, where he completed his undergraduate degree, followed by a medical degree from the University of California, San Diego. His postgraduate training included a general surgery residency at Massachusetts General Hospital and a surgical oncology fellowship at Memorial Sloan Kettering Cancer Center, a renowned Comprehensive Cancer Center.
Before taking on his current role, he was an attending surgeon at Memorial Sloan Kettering Cancer Center's Division of Gastric and Mixed Tumors. He served as a professor at Weill Cornell Medical College. He also held an associate professorship at Massachusetts General Hospital and Harvard Medical School before moving to Memorial Sloan Kettering in 2012.
He is at the forefront of minimally invasive robotic surgery, having performed over 300 such procedures, including advanced robotic gastrectomies. This innovative surgical technique involves smaller incisions and sophisticated robotic technology, which enhances precision and reduces recovery times. He has authored over 150 original research articles, book chapters, and reviews. Additionally, he is actively involved in significant research funded by organizations such as Stand Up To Cancer and the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research, which aims to develop early diagnostic tests and new treatments.
Dr. Sam Yoon's dedication to surgical oncology and drive to improve patient outcomes through advanced surgical techniques and research has solidified his position as a leader in his field.
